Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,039 | 3 | 50.6% |
| Food and Beverage | $7,124 | 292 | 39.9% |
| Travel and Lodging | $1,424 | 6 | 8.0% |
| Education | $269.36 | 8 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $6,934 | 29 | $0 (2024) |
| Janssen Biotech, Inc. | $4,068 | 20 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $935.21 | 15 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $717.35 | 16 | $0 (2024) |
| PFIZER INC. | $530.49 | 34 | $0 (2024) |
| Coloplast Corp | $449.66 | 10 | $0 (2022) |
| Astellas Pharma US Inc | $426.09 | 36 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $375.21 | 9 | $0 (2024) |
| NeoTract Inc. | $277.50 | 5 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $251.40 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,060 | 50 | Janssen Biotech, Inc. ($3,788) |
| 2023 | $934.96 | 41 | Teleflex LLC ($136.50) |
| 2022 | $7,361 | 37 | Bayer HealthCare Pharmaceuticals Inc. ($6,515) |
| 2021 | $286.53 | 17 | Antares Pharma, Inc. ($69.54) |
| 2020 | $209.26 | 12 | 180 Medical, Inc. ($53.73) |
| 2019 | $1,994 | 55 | Dendreon Pharmaceuticals LLC ($660.44) |
| 2018 | $891.11 | 44 | PFIZER INC. ($226.43) |
| 2017 | $1,119 | 53 | NeoTract Inc. ($277.50) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $25.83 | General |
| 12/20/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Urology | ||||||
| 12/13/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $157.50 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: HORMONE THERAPY | ||||||
| 11/21/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $25.09 | General |
| 11/19/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $13.18 | General |
| 11/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: HORMONE THERAPY | ||||||
| 10/28/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/24/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: Oncology | ||||||
| 09/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.23 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/20/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $89.58 | General |
| Category: Urology | ||||||
| 08/09/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Immunotherapy | ||||||
| 07/23/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: ONCOLOGY | ||||||
| 07/08/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Oncology | ||||||
| 06/28/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/21/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 4,426 | 9,603 | $794,750 | $366,356 |
| 2022 | 58 | 4,803 | 15,425 | $915,578 | $469,930 |
| 2021 | 70 | 5,784 | 19,289 | $1.2M | $624,034 |
| 2020 | 63 | 5,343 | 19,866 | $1.1M | $525,279 |
All Medicare Procedures & Services
235 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 875 | 1,295 | $187,190 | $122,020 | 65.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 3,120 | $75,480 | $56,899 | 75.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 150 | 176 | $71,750 | $32,982 | 46.0% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 81 | 83 | $47,845 | $23,232 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 202 | 231 | $23,760 | $15,022 | 63.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 120 | 120 | $27,000 | $14,512 | 53.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 12 | 93 | $65,100 | $12,342 | 19.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 180 | 312 | $44,144 | $11,489 | 26.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 33 | 164 | $11,480 | $8,163 | 71.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 322 | 402 | $14,070 | $7,244 | 51.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 79 | 101 | $10,475 | $6,585 | 62.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 44 | $8,865 | $5,978 | 67.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 48 | $7,920 | $5,206 | 65.7% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 130 | 235 | $27,016 | $4,574 | 16.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 39 | 39 | $11,700 | $4,233 | 36.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 1,039 | 1,791 | $10,746 | $3,896 | 36.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 31 | 32 | $28,800 | $3,894 | 13.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 354 | 465 | $13,950 | $3,783 | 27.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 17 | 17 | $8,500 | $3,409 | 40.1% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2023 | 13 | 17 | $32,725 | $2,887 | 8.8% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 125 | 147 | $5,586 | $2,649 | 47.4% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 14 | 14 | $4,425 | $2,206 | 49.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 26 | 30 | $3,000 | $2,083 | 69.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 36 | $2,520 | $1,520 | 60.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,320 | $1,400 | 60.3% |
About Dr. Brian Seifman, MD
Dr. Brian Seifman, MD is a Urology healthcare provider based in West Bloomfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831171669.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Seifman, MD has received a total of $17,856 in payments from pharmaceutical and medical device companies, with $5,060 received in 2024. These payments were reported across 309 transactions from 46 companies. The most common payment nature is "Consulting Fee" ($9,039).
As a Medicare-enrolled provider, Seifman has provided services to 20,356 Medicare beneficiaries, totaling 64,183 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 235 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location West Bloomfield, MI
- Active Since 11/17/2005
- Last Updated 07/19/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1831171669
Products in Payments
- Nubeqa (Drug) $6,684
- ERLEADA (Drug) $4,089
- PROVENGE (Drug) $935.21
- FIRMAGON (Drug) $615.78
- XTANDI (Drug) $352.57
- Urolift - UL400 (Device) $277.50
- Xofigo (Drug) $250.23
- LYNPARZA (Drug) $216.80
- AQUABEAM ROBOTIC SYSTEM (Device) $206.90
- Erleada (Drug) $205.24
- KEYTRUDA (Biological) $199.09
- Prolia (Biological) $178.82
- Axumin (Drug) $169.36
- MYRBETRIQ (Drug) $167.82
- ENDOUROLOGY (Device) $163.87
- PROLARIS (Device) $160.57
- Myrbetriq (Drug) $152.40
- SUTENT (Drug) $140.76
- Porges Coloplast (Device) $140.57
- JEVTANA (Drug) $136.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in West Bloomfield
Jason Hafron, Md, MD
Urology — Payments: $583,528
Gregory Oldford, Md, MD
Urology — Payments: $69,542
Jennifer Sobol, Do, DO
Urology — Payments: $34,022
Mitchell Hollander, Md, MD
Urology — Payments: $23,171
Dr. James Relle, Md, MD
Urology — Payments: $6,881
Dr. Stephen Liroff, M.d, M.D
Urology — Payments: $2,858